JDDonline

Explore the Journal of Drugs in Dermatology (JDD), a monthly peer-reviewed, PubMed® indexed dermatology journal & online resource.

Complimentary subscriptions for US dermatologists, dermatology residents, nurse practitioners and physician assistants.

Early Online

CURRENT ISSUE HIGHLIGHTS

Combined Use of Relabotulinum Toxin A and NASHA Gel Skinbooster for Rejuvenation of the Upper Third of the Face

Published online December 23, 2025

Rejuvenation of the upper third of the face is integral to achieving comprehensive facial aesthetic restoration. Prominent age-related ...

read more
Updated Insights From an Expanded Survey on Monopolar Radiofrequency Treatment

Published online December 23, 2025

Thermage ® FLX is an advanced, non-invasive monopolar radiofrequency (RF) device used in aesthetic dermatology to address skin lax...

read more
Astragalus membranaceus Extract as a Botanical Ingredient for Pigmentary and Anti-Aging Skincare: A Systematic Review

Published online December 22, 2025

Skin aging is an inevitable biological process, regardless of skin type. This natural progression of dermal senescence is influenced by...

read more
Photodistributed Hyperpigmentation Associated With COVID-19 Vaccination

Published online December 22, 2025

Up to twenty percent of all cases of acquired hyperpigmentation are postulated to be drug-induced. The incidence and pathogenesis of dr...

read more
Sunless Tanners in Dermatology: A Review of Ingredients, Efficacy, and Safety Profiles

Published online December 19, 2025

Sunless tanners offer an alternative to traditional tanning methods that involve exposure to ultraviolet (UV) radiation. Dermatologists...

read more
Halo Seborrheic Keratosis in a Patient of Color With Vitiligo

Published online December 15, 2025

Practice Points Depigmented halos are not restricted to melanocytic lesions; SK can rarely display a halo and may clinically r...

read more
Social Media Analysis of #LipFiller: Content and Quality

Published online December 15, 2025

The popularity of fillers for lip enhancement—commonly referred to as "lip fillers"--has grown substantially in recent years. 1,2...

read more
Private Insurance Coverage for Botulinum Toxin for Primary Axillary Hyperhidrosis: A Cross-Sectional Analysis

Published online December 11, 2025

Axillary hyperhidrosis is a chronic dermatological condition characterized by excessive underarm sweating, often interfering with daily...

read more

Current Issue

Explore JDDonline
Subscribe to JDD

Discover the latest research, exclusive articles from leading dermatology experts – Subscribe to the JDD today. Complimentary subscriptions available for US dermatologists, dermatology residents, dermatology nurse practitioners & physician assistants.

Subscribe Now

Latest News

Journal of Drugs in Dermatology JDD Article about Clinical Evaluation of Thiamidol-Containing Formulations for the Visual Management of Facial Hyperpigmentation

Clinical Evaluation of Thiamidol-Containing Formulations for the Visual Management of Facial Hyperpigmentation

| Dyspigmentation, Featured Articles, Latest News | No Comments
Thiamidol shows rapid, sustained benefit for facial hyperpigmentation We’re highlighting a December 2025  article that we’re sure you’ll want to dive into! A 90‑patient randomized study found that thiamidol formulations…

New Innovations of SkinCeuticals and Antioxidants Review

| JDD Highlights, JDD Webinars, The Latest, Video Abstract | No Comments
Join Dr. Jared Jagdeo, a board certified dermatologist, to learn more about new innovations of SkinCeuticals. Dr. Jagdeo will present a review of the latest antioxidant science from SkinCeuticals. Faculty…

Optimizing Patient Outcomes with Adjunctive OTC Skincare​

| JDD Highlights, JDD Webinars, The Latest, Video Abstract | No Comments
Join Dr. Ted Lain, Chief Medical Officer at Sanova Dermatology, and Star Walsh, R&D Director at Neutrogena®, for an informative webinar on the latest science and role of adjunctive OTC…
Journal of Drugs in Dermatology JDD Article about Private Insurance Coverage for Botulinum Toxin for Primary Axillary Hyperhidrosis: A Cross-Sectional Analysis

Private Insurance Coverage for Botulinum Toxin for Primary Axillary Hyperhidrosis: A Cross-Sectional Analysis

| Derm Community, Featured Articles, Latest News | No Comments
Coverage clears the way: Most large private insurers pay for Botox and friends for axillary hyperhidrosis In one of our January JDD articles, we reviewed public medical‑policy guidance from the…

Year in Review: 2025 Highlights From JDD

| Featured Articles, Latest News | No Comments
Despite millennia of observation and modern understanding of HPV, treatment choices remain trade‑offs between efficacy, speed and tolerability From the Editor-in-Chief Dear Readers, As we look back on 2025, one…

The Best Sunscreen is the One Your Patients Will Use and Other Truths

| JDD Highlights, JDD Webinars, The Latest, Video Abstract | No Comments
Behind all sunscreen is a scientific story, the photobiology, toxicology and public perception.  Yet, the science often gets lost in the noise of misconceptions and outdated narratives.  Join Adam Friedman…
View all Derm News

News Topics

JDD Newsletter

Sign up for the JDD eNewsletter for exclusive articles, case reports, Podcast episodes, free CME activities, and more!

Subscribe

JDD Podcast

AD Treatment – The Future Landscape

| Atopic Dermatitis, Featured Podcast, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Drs. Amy Paller, Jonathan Silverberg & Adam Friedman   Consider this final episode of the 5 part all you can handle Atopic Dermatitis series the…
Tune In

Follow Us